Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2025)

Amphastar Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 8 years, most recently at $16.4 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $16.4 million for Q4 2025, up 119.7% from a year ago — trailing twelve months through Dec 2025 was $90.3 million (down 28.35% YoY), and the annual figure for FY2025 was $90.3 million, down 28.35%.
  • Change in Acquisitions & Divestments for Q4 2025 was $16.4 million at Amphastar Pharmaceuticals, down from $22.5 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for AMPH hit a ceiling of $65.8 million in Q2 2024 and a floor of -$179000.0 in Q4 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $10.1 million (2022), compared with a mean of $15.1 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 101.43% in 2023 and later soared 4281.01% in 2024.
  • Amphastar Pharmaceuticals' Change in Acquisitions & Divestments stood at $1.3 million in 2021, then soared by 827.6% to $12.5 million in 2022, then tumbled by 101.43% to -$179000.0 in 2023, then soared by 4281.01% to $7.5 million in 2024, then surged by 119.7% to $16.4 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $16.4 million (Q4 2025), $22.5 million (Q3 2025), and $23.0 million (Q2 2025) per Business Quant data.